Dorj Narangerel
Overview
Explore the profile of Dorj Narangerel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von Mollendorf C, Mungun T, Ulziibayar M, Nguyen C, Batsaikhan P, Suuri B, et al.
Lancet Microbe
. 2024 Nov;
5(12):100929.
PMID: 39486429
Background: Data on changes in pneumococcal serotypes in hospitalised children following the introduction of the pneumococcal conjugate vaccine (PCV) in low-income and middle-income countries are scarce. In 2016, Mongolia introduced...
2.
von Mollendorf C, Mungun T, Ulziibayar M, Skoko P, Boelsen L, Nguyen C, et al.
Nat Commun
. 2024 Aug;
15(1):6577.
PMID: 39097620
Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction on pneumococcal carriage. Here we assess the impact of 13-valent pneumococcal conjugate vaccine (PCV13) introduction on...
3.
Respiratory Syncytial Virus and Influenza Infections in Children in Ulaanbaatar, Mongolia, 2015-2021
Do L, Tsedenbal N, Khishigmunkh C, Tserendulam B, Altanbumba L, Luvsantseren D, et al.
Influenza Other Respir Viruses
. 2024 May;
18(5):e13303.
PMID: 38757258
Background: Data available for RSV and influenza infections among children < 2 years in Mongolia are limited. We present data from four districts of Ulaanbaatar from April 2015 to June...
4.
Do L, Tsedenbal N, Khishigmunkh C, Tserendulam B, Altanbumba L, Luvsantseren D, et al.
IJID Reg
. 2024 Apr;
11:100357.
PMID: 38577554
Objectives: Limited data indicate a beneficial effect of pneumococcal conjugate vaccines (PCVs) on respiratory syncytial virus (RSV) and influenza infections in young children. We evaluated the impact of 13-valent PCV...
5.
von Mollendorf C, Ulziibayar M, Nguyen C, Batsaikhan P, Suuri B, Luvsantseren D, et al.
Emerg Infect Dis
. 2024 Feb;
30(3):490-498.
PMID: 38407131
Starting in June 2016, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the routine immunization program of Mongolia by using a 2+1 dosing schedule, phased by district. We used...
6.
Fagerli K, Ulziibayar M, Suuri B, Luvsantseren D, Narangerel D, Batsaikhan P, et al.
Lancet Reg Health West Pac
. 2023 Dec;
44:100983.
PMID: 38143716
Background: Few studies have assessed the potential indirect effects of childhood pneumococcal conjugate vaccine (PCV) programs on the adult pneumonia burden in resource-limited settings. We evaluated the impact of childhood...
7.
Fagerli K, Ulziibayar M, Suuri B, Luvsantseren D, Narangerel D, Batsaikhan P, et al.
Lancet Reg Health West Pac
. 2022 Nov;
30:100591.
PMID: 36419739
Background: Community-acquired pneumonia is a leading cause of morbidity and mortality among children and adults worldwide. Adult pneumonia surveillance remains limited in many low- and middle-income settings, resulting in the...
8.
von Mollendorf C, Ulziibayar M, Gessner B, Do L, Nguyen C, Beavon R, et al.
BMC Public Health
. 2021 Sep;
21(1):1731.
PMID: 34556065
Background: Community-acquired pneumonia is an important cause of morbidity and mortality in adults. Approximately one-third of pneumonia cases can be attributed to the pneumococcus. Pneumococcal conjugate vaccines (PCVs) protect against...
9.
von Mollendorf C, Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, Narangerel D, et al.
PLoS One
. 2019 Sep;
14(9):e0222423.
PMID: 31509593
Background: Respiratory diseases, including pneumonia, are the second largest cause of under-five mortality in Mongolia and the most common cause of childhood hospitalization. However information regarding the contribution of Streptococcus...
10.
von Mollendorf C, Dunne E, Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, et al.
Vaccine
. 2019 Jun;
37(30):4068-4075.
PMID: 31174939
Background: Nasopharyngeal carriage of Streptococcus pneumoniae precedes disease, is the source of pneumococcal community spread, and the mechanism for herd protection provided by pneumococcal conjugate vaccines (PCVs). There are few...